3 Factor Indexing’s Moderna MRNA Stock Holding History

3 Factor Indexing’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$193	Buy	+1	New	+$108	﹤0.01%	284

Other funds holding MRNA

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

Beau Ventures, LLc Pittsford, New York $1.06B AUM 83.06% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

LAI

Legal Advantage Investments Los Altos Hills, California $468M AUM 7.83% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

3 Factor Indexing's MRNA Position: Q3 2026 in Review

3 Factor Indexing opened a new position in Moderna (MRNA) in Q3 2026: 1 share worth $193. The stake represents ﹤0.01% of the portfolio and ranks #284 among its holdings.

221 funds tracked by Wall St. Rank hold MRNA as of Q3 2026.

3 Factor Indexing held 1 share of Moderna worth $193 as of Q3 2026.
Moderna was a new 3 Factor Indexing position in Q3 2026.
Moderna made up ﹤0.01% of 3 Factor Indexing's portfolio in Q3 2026, its #284 holding.
221 funds tracked by Wall St. Rank held Moderna as of Q3 2026.

Based on 3 Factor Indexing's 13F filing for Q3 2026, filed 15 Oct 2026.